The Helsinki-based company, which develops intravenously delivered cancer immunotherapies, evaluated TILT-123 (igrelimogene litadenorepvec) together with...
EBITDA rose to NOK 13.6 million from NOK 8.4 million, lifting the margin to 27%...
The analysis was based on efficacy data from about the first 100 randomized patients who...
Today’s blood supply chains face significant logistical challenges, including limited access to universal AB plasma....
The Copenhagen-based company’s drug candidate, RTP-026, is designed to protect the heart from further damage...
They discuss the challenges of distributing temperature- and light-sensitive investigational medicinal products, the hidden cost...
“Scale-up” sounds like a problem of size. A process works in the laboratory; the next...
EECC is designed to be delivered outside intensive care units and requires all medical staff...
The new panel adds cefiderocol and other reserve antibiotics to the QuickMIC portfolio, giving laboratories...
IZIPRY is built on Orexo’s powder-based drug delivery platform, AmorphOX, and is designed to reverse...
Third-quarter sales were USD 250 million, up 4% organically and 5% reported. Prosthetics and Neuro...
The stockpile is managed by the International Coordinating Group (ICG) on Vaccine Provision, a WHO-hosted...
The award was presented for the first time at Forska!Sverige Day on October 21, 2026....
Under the agreement, Biossil acquires the global rights to mitazalimab and its derivatives across all...
Sales of Medistim’s own products rose 34.6% in currency-neutral terms. All regions grew: the Americas...
